Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Other financing activities: 2009-2025

Historic Other financing activities for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $435,000.

  • Lifecore Biomedical's Other financing activities fell 95.51% to $107,000 in Q2 2024 from the same period last year, while for May 2024 it was $6.8 million, marking a year-over-year increase of 1.04%. This contributed to the annual value of $435,000 for FY2025, which is 88.31% up from last year.
  • Lifecore Biomedical's Other financing activities amounted to $435,000 in FY2025, which was up 88.31% from $231,000 recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Other financing activities registered a high of $10.5 million during FY2021, and its lowest value of $231,000 during FY2024.
  • Over the past 3 years, Lifecore Biomedical's median Other financing activities value was $435,000 (recorded in 2025), while the average stood at $2.2 million.
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 636.91% in 2023, then slumped by 96.18% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Other financing activities (Yearly) stood at $10.5 million in 2021, then plummeted by 92.17% to $821,000 in 2022, then spiked by 636.91% to $6.0 million in 2023, then crashed by 96.18% to $231,000 in 2024, then skyrocketed by 88.31% to $435,000 in 2025.